Ttbio Corp.
Ttbio Corp. manufactures, sells, and maintains medical devices under the TTBIO brand name in Taiwan and the United States. The company offers high and low-speed hand piece products, dental spare parts, service rotors, maintenance units, electric hand piece systems, and precision-machined components. It serves various industries, including medical, automotive, aerospace, security, computer compone… Read more
Ttbio Corp. (6493) - Total Liabilities
Latest total liabilities as of June 2025: NT$354.31 Million TWD
Based on the latest financial reports, Ttbio Corp. (6493) has total liabilities worth NT$354.31 Million TWD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Ttbio Corp. - Total Liabilities Trend (2019–2024)
This chart illustrates how Ttbio Corp.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Ttbio Corp. Competitors by Total Liabilities
The table below lists competitors of Ttbio Corp. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Freedom Internet Group Inc
PINK:FIGI
|
USA | $655.00 |
|
Huntington Exploration Inc
PINK:HEXPF
|
USA | $261.12K |
|
Hour Loop Inc
NASDAQ:HOUR
|
USA | $23.95 Million |
|
Energoaparatura S.A.
WAR:ENP
|
Poland | zł15.31 Million |
|
HB Global Ltd
KLSE:5187
|
Malaysia | RM58.38 Million |
|
RFG Holdings Ltd
JSE:RFG
|
South Africa | ZAC2.14 Billion |
|
Universal Ibogaine Inc
PINK:IBOGF
|
USA | $3.73 Million |
|
Bioalpha Holdings Bhd
KLSE:0179
|
Malaysia | RM13.51 Million |
Liability Composition Analysis (2019–2024)
This chart breaks down Ttbio Corp.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.61 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.24 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.55 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ttbio Corp.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ttbio Corp. (2019–2024)
The table below shows the annual total liabilities of Ttbio Corp. from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | NT$313.18 Million | +47.61% |
| 2023-12-31 | NT$212.17 Million | +4.20% |
| 2022-12-31 | NT$203.61 Million | +20.29% |
| 2021-12-31 | NT$169.26 Million | +36.01% |
| 2020-12-31 | NT$124.45 Million | -15.91% |
| 2019-12-31 | NT$148.00 Million | -- |